Back to
Boston Partners
GILDShowing 3 of 12 quarters
Position history for
Boston Partners's holdings in GILEAD SCIENCES INC
Yes. Boston Partners holds 6,017,958 shares of GILD (Gilead Sciences), worth $761.6M, as of its Q2 2026 13F filing. It increased the position by 1,762,836 shares (+41.4%) from Q1 2026. Boston Partners has held GILD since Q4 2025, across 3 quarterly 13F filings. GILD is 0.7% of Boston Partners' reported 13F portfolio.
Current Value
$761.6M
Current Shares
6M
Total Value Change
+$243.8M
Total Shares Change
+1.8M
Quarter-by-Quarter History
Other major holders of GILD: BlackRock, Inc., VANGUARD GROUP INC